Posted by Michael Wonder on 07 Aug 2023
Alberta will cover pricey drug believed to extend and enhance lives of ALS patients
7 August 2023 - People diagnosed with ALS are usually given two to five years to live.
Albertans living with ALS, commonly referred to as Lou Gehrig's Disease, have a new treatment option that can improve their quality of life and help them live longer — one the Alberta Government will cover for the estimated $18,500 a month per patient.
On 1 August, the province added the trademark drug, Albrioza, to the Alberta Drug Benefit List, which allows eligible patients to be reimbursed for the cost of the treatment.
